Physician profile
Peter J Ostergaard
NPI 1790134096
$14,674.89
in general payments reported to CMS, 2019-2025
13 companies · $445 in 2025
The $445 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $618 · 2020: $51.66 · 2021: $12K · 2022: $1,767 · 2023: $118 · 2024: $163 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $725.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,028.76 | 2021-2023 | Distal Extremities Implants Soft Tissue Ib Ligament Augmentation |
| Medwest Associates | $1,203.66 | 2022 | |
| Evolution Surgical, INC | $1,200.00 | 2021 | |
| Stryker Corporation | $942.57 | 2019-2025 | Conextions Tr Tendon Repair System-Implant Mechanism, Variax |
| Acumed LLC | $573.72 | 2022-2025 | Acumed, Inframe Implant, Osteomed |
| Axogen | $241.87 | 2021-2023 | Avance Nerve Graft |
| Tenex Health INC. | $147.88 | 2021 | |
| Extremity Medical | $146.94 | 2022 | |
| Endo USA, INC. | $71.50 | 2025 | Xiaflex |
| Skeletal Dynamics INC | $51.66 | 2020 | |
| Endo Pharmaceuticals INC. | $23.91 | 2023 | Xiaflex |
| Djo, LLC | $21.25 | 2023 | Cmf |
| Polynovo North America LLC | $21.17 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Ostergaard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.